innoscripta SE
50.70EUR
-1.5000 (-2.87%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on 1INN.DE.
Revenue
| (EUR) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 27.3M | 39.4M | 64.7M | 103.4M | 148.0M | 200.0M |
| Q1 | — | — | — | — | 40.3M | — |
| Q2 | — | — | — | 18.5M | 22.8M | — |
| Q3 | — | — | — | 26.6M | — | — |
| Q4 | — | — | — | 32.7M | — | — |
Revenue
| (EUR) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | .610 | 1.03 | 2.51 | 4.26 | 23.54 | 30.81 |
| Q1 | — | — | — | 1.09 | 1.84 | — |
| Q2 | — | — | — | — | — | — |
| Q3 | — | — | — | — | — | — |
| Q4 | — | — |
Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| — |
| 1.47 |
| — |
| — |
Debt level and coverage